AstraZeneca
AstraZeneca is a global, science-led, patient-focused pharmaceutical company dedicated to accelerating the delivery of life-changing medicines. They are committed to transforming healthcare through scientific innovation, with a focus on oncology, cardiovascular, renal & metabolism, respiratory & immunology, vaccines, and rare diseases. Their strategy aims to lead in disease areas, transform patient outcomes, and achieve significant revenue growth by 2030.
Industries
Nr. of Employees
Very Large (1000+)
Products
Machine learning disease-prediction tool
A machine learning tool used for early disease detection and to support drug discovery and target identification workflows.
Externally sponsored research programme
Program to enable external investigators to access compounds and data for preclinical and clinical research under collaborative agreements.
Machine learning disease-prediction tool
A machine learning tool used for early disease detection and to support drug discovery and target identification workflows.
Externally sponsored research programme
Program to enable external investigators to access compounds and data for preclinical and clinical research under collaborative agreements.
Services
End-to-end alliance governance, integration support and dedicated alliance managers to structure and operate scientific and commercial collaborations.
Platform granting external researchers access to compound libraries, optimised compounds, data and know-how for preclinical and non-oncology clinical research.
Supplier portals, e-invoicing and supply chain financing options to manage invoicing, payments and supplier onboarding.
End-to-end alliance governance, integration support and dedicated alliance managers to structure and operate scientific and commercial collaborations.
Platform granting external researchers access to compound libraries, optimised compounds, data and know-how for preclinical and non-oncology clinical research.
Supplier portals, e-invoicing and supply chain financing options to manage invoicing, payments and supplier onboarding.
Expertise Areas
- Clinical trial management and data visualisation
- Cell and gene therapy R&D
- Next-generation therapeutic modalities
- Genomics and population-scale sequencing
Key Technologies
- Machine learning / AI
- Graph neural networks
- Next-generation sequencing (NGS)
- CRISPR and genome editing
News & Updates
A landmark investment reflecting confidence in AstraZeneca’s innovative medicines to transform global health and power AstraZeneca’s ambition to deliver $80 billion revenue by 2030.
A feature article on sustainable respiratory care and the transition to pMDIs with near-zero GWP propellant.
An article on AstraZeneca's efforts to improve lung health equity.
A landmark investment reflecting confidence in AstraZeneca’s innovative medicines to transform global health and power AstraZeneca’s ambition to deliver $80 billion revenue by 2030.
A feature article on sustainable respiratory care and the transition to pMDIs with near-zero GWP propellant.
An article on AstraZeneca's efforts to improve lung health equity.